Updates are available Correction dated 2021-05-20
Click to view Correction: https://doi.org/10.1007/s11060-021-03769-9
-
Authors
Dijkstra, Bianca M. https://orcid.org/0000-0001-6802-7021
de Jong, Marion
Stroet, Marcus C. M.
Andreae, Fritz
Dulfer, Sebastiaan E.
Everts, Marieke
Kruijff, Schelto
Nonnekens, Julie
den Dunnen, Wilfred F. A.
Kruyt, Frank A. E. https://orcid.org/0000-0002-2445-9380
Groen, Rob J. M. https://orcid.org/0000-0003-3067-763X
-
Funding
Funding for this research was provided by:
Universitair Medisch Centrum Groningen
Rijksuniversiteit Groningen
de Cock-Hadders stichting
- License Information
-
More Information
Article History
Received: 26 January 2021
Accepted: 12 March 2021
First Online: 26 March 2021
Change Date: 20 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11060-021-03769-9
Declarations
:
: WdD was member of the advisory board for GBM diagnostic testing for AbbVie. MdJ and JN have an unrelated investigator-initiated project contract with Advanced Accelerator Applications, a Novartis company. FA is CEO of piCHEM Forschungs und EntwicklungsGmbH, Raaba-Grambach, Graz, Austria.
: Informed consent was obtained from all individual participants included in the study. If informed consent could not be obtained, the Code of Conduct for responsible use of human tissue was followed.
: Patients signed informed consent regarding publishing their anonymized data and photographs.
: Ethics of animal and human research subjects has been reviewed by the Institutional Review Board of the University of Groningen and University Medical Centre Groningen. Animal care complied with the Guide for the Care and Use of Laboratory Animals. For patient material, the Board approved the experimental protocol and informed consent.
